Clinical Trial Update: Study of YKST02 Alone or in Combination With YK012 in Patients With Active or Refractory Systemic Lupus Erythematosus [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating YKST02 alone or in combination with YK012 for active or refractory systemic lupus erythematosus; the study is not yet recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• YK012
• YKST02

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: System Lupus Erythematosus(SLE) | Phase 1 | Status: NOT_YET_RECRUITING